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Abstract
Dengue virus (DENV) is the leading cause of mosquito-borne viral illness and death in humans. Like many viruses, DENV has
evolved potent mechanisms that abolish the antiviral response within infected cells. Nevertheless, several in vivo studies
have demonstrated a key role of the innate immune response in controlling DENV infection and disease progression. Here,
we report that sensing of DENV infected cells by plasmacytoid dendritic cells (pDCs) triggers a robust TLR7-dependent
production of IFNa, concomitant with additional antiviral responses, including inflammatory cytokine secretion and pDC
maturation. We demonstrate that unlike the efficient cell-free transmission of viral infectivity, pDC activation depends on
cell-to-cell contact, a feature observed for various cell types and primary cells infected by DENV, as well as West Nile virus,
another member of the Flavivirus genus. We show that the sensing of DENV infected cells by pDCs requires viral envelope
protein-dependent secretion and transmission of viral RNA. Consistently with the cell-to-cell sensing-dependent pDC
activation, we found that DENV structural components are clustered at the interface between pDCs and infected cells. The
actin cytoskeleton is pivotal for both this clustering at the contacts and pDC activation, suggesting that this structural
network likely contributes to the transmission of viral components to the pDCs. Due to an evolutionarily conserved
suboptimal cleavage of the precursor membrane protein (prM), DENV infected cells release uncleaved prM containing-
immature particles, which are deficient for membrane fusion function. We demonstrate that cells releasing immature
particles trigger pDC IFN response more potently than cells producing fusion-competent mature virus. Altogether, our
results imply that immature particles, as a carrier to endolysosome-localized TLR7 sensor, may contribute to regulate the
progression of dengue disease by eliciting a strong innate response.
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Introduction
The innate immune system acts as the first line of defense for the
sensing of viral infection. This involves rapid recognition of
pathogen-associated molecular patterns (PAMPs), including viral
nucleic acids, by pattern recognition receptors (PRRs). This
recognition results in an antiviral response characterized by the
production of type I interferons (IFNs) and expression of IFN-
stimulated genes (ISGs). This response suppresses viral spread by
blocking the viral life cycle at multiple levels and also mediates
immunomodulatory effects in surrounding tissues that impart the
onset of the adaptive immune response [1]. The PRR can be
cytoplasmic, e.g., retinoic inducible gene-I (RIG-I)-like receptors
(RLRs) and NOD-like receptors (NLRs), or endosomal, e.g.,
Toll-like receptors (TLRs) [1]. Thus, depending on their
intracellular localization, virus-induced innate immune signaling
typically occurs within cells that are either productively infected or
that have internalized viral particles [1,2].
Recent studies illustrated the existence of alternative host
sensing strategies by bystander plasmacytoid dendritic cells
(pDCs), which recognize infected cells [3,4,5,6,7]. pDCs are
immune cells known to function as sentinels of viral infection and
are a major type I IFN-producing cell type in vivo [8,9]. Using
hepatitis C virus (HCV) as a model, we recently demonstrated that
HCV infected cells can selectively package immunostimulatory
viral RNA within exosomes that deliver their RNA cargo to pDCs,
which, in turn, produce IFNa [3]. Exosomes also permit transfer
to pDCs of distinct immunostimulatory viral RNAs, such as those
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of the negative strand lymphocytic choriomeningitis virus (LCMV)
[4]. This sensing pathway is thought to assure recognition of
infected cells and hence protects the host against viruses that defeat
the pathogen-sensing machinery within the cells they infect.
Virtually all viruses have evolved strategies that preclude
antiviral signaling in the cell they infect [10]. For example,
dengue virus (DENV) has evolved several evasion strategies that
prevent IFN and ISG expression within infected cells [11].
Notably, the DENV NS2B-3 protease complex, by cleavage and
degradation of an adapter of the cytoplasmic sensor-mediated
signaling (STING, also called MITA) and by preventing
phosphorylation and nuclear translocation of the downstream
transcriptional factor, IFN regulatory 3 (IRF3), inhibits type I IFN
production in DENV infected cells [12,13,14,15]. Despite these
potent inhibitory mechanisms, expression of antiviral and inflam-
matory molecules is readily detected in DENV infected humans
[16,17]. Their levels play a pivotal role in DENV infection
clearance and pathogenicity [16,18,19], thus highlighting the
importance of elucidating the host sensing mechanisms leading to
the IFN response during DENV infection.
Here, we showed that pDCs are robust IFNa producer cells in
response to DENV infected cells. In addition, we demonstrated
that cell-to-cell contact- and TLR7-dependent pDC responsive-
ness leads to an antiviral state, inflammatory cytokine production
as well as expression of co-stimulatory molecules by pDCs. Newly
formed particles of DENV, like many viruses, undergo maturation
by cleavage of the virus envelope protein, premembrane (prM), in
the secretory pathway that renders the virus infectious [20]. Yet,
the prM cleavage site is suboptimal, leading to the secretion of
about 30–40% immature, prM-bearing particles [21,22,23,
24,25,26]. This evolutionarily conserved suboptimal site may be
critical for the export of the infectious viral particles and/or may
also positively contribute to viral infection by usurpation of
humoral immune response, because anti-prM antibodies facilitate
efficient binding and cell entry of prM-containing immature
particles into Fc-receptor-expressing cells, a process called
antibody dependent enhancement (ADE) [21,22,23,27,28]. Here,
we report a previously unsuspected function of immature particles
in innate immunity. Although the immature particles are not
infectious, they are fully competent to trigger a robust type I IFN
response by contacting non-permissive pDCs. Our results high-
light the trade-off between efficient secretion of infectious viral
particles and the production of a large amount of IFN-inducing
immature particles.
Results
IFNa is robustly produced by pDCs in contact with DENV
infected cells
To investigate the mechanisms regulating the IFN response
against DENV infection, primary human peripheral blood
mononuclear cells (PBMCs) from healthy donors were exposed
to supernatants containing DENV virions or DENV infected cells.
We found that PBMCs specifically responded to co-cultivation
with DENV infected cells but not to uninfected Huh7.5.1 cells, by
a robust secretion of IFNa (Figure 1A). In sharp contrast,
supernatants from the DENV infected cells failed to trigger IFNa
secretion by PBMCs (Figure 1A). Plasmacytoid dendritic cells
(pDCs), which represent a rare PBMC population, i.e. 0.41% of
PBMCs (Figure 1B, upper panel), are known to produce IFNa [9].
Antibody-mediated pDC depletion from PBMCs (Figure 1B,
middle panel) abolished IFNa secretion in response to co-culture
with DENV infected cells (Figure 1A). Similar results were also
obtained using DENV infected BHK-21 cells (Figures S1A and
S1B). To rule out potential non-specific effects of the depletion
procedure on innate cell responsiveness, we verified that IL-6
production triggered by lipopolysaccharide (LPS) exposure was
maintained after pDC depletion (Figures 1C and S1C). Consistent
with the depletion results, the isolated pDC population (Figure 1B,
lower panel) potently produced IFNa in response to co-culture
with DENV infected cells, but not in the presence of their
supernatants (Figure 1A). A very limited number of pDCs (i.e.,
2,000 pDCs) was sufficient to produce a robust secretion of IFNa
(Figure 1A). Similar levels of IFNa production were detected after
co-culture of infected cells with isolated pDCs as compared to total
PBMCs, which contained a similar number of pDCs (Figure 1D),
further suggesting that pDCs are the main IFNa producer cells
among PBMCs. We showed that the cells productively infected
with DENV did not produce IFNa themselves (Figure S2A). The
pDC IFNa response increased as the duration of infection and,
thus the replication levels, prior to co-culture increased (Figure
S2A). Remarkably, similar levels of IFNa secretion were repro-
ducibly obtained with pDCs isolated from the blood of a cohort of
20 healthy donors (Figure 1E). Together these results suggest that
pDCs represent the main cell type in PBMC populations that
produce IFN in response to co-cultivation with DENV infected
cells and that this response was not induced by the addition of cell-
free supernatants containing virus.
To exclude the possibility that pDCs respond transiently to
supernatants containing DENV, we quantified IFNa secretion in
time course experiments. IFNa secretion was already detectable as
early as 4 hours after co-cultivation of pDCs and DENV infected
cells (Figure 2A). IFNa levels concurrently increased over the time
course of co-culture of DENV infected cells with either pDCs or
PBMCs, and reached levels around 100 ng/mL after 16 hours of
co-culture (Figure 2A). In contrast, cell-free supernatants contain-
ing DENV did not trigger detectable IFNa production by pDCs or
by PBMCs at any of time points analyzed (Figure 2A). IFNa
Author Summary
Viral recognition by the host often triggers an antiviral
state, which suppresses viral spread and imparts adaptive
immunity. Like many viruses, dengue virus (DENV) defeats
the host-sensing pathway within infected cells. However,
in vivo studies have demonstrated a key role of innate
immunity in controlling DENV infection. Here we report
that sensing of DENV-infected cells by non-permissive
innate immune cells, the plasmacytoid dendritic cells
(pDCs), triggers a cell-contact- and TLR7-dependent
activation of a strong antiviral IFN response. This cell-to-
cell sensing involves transmission of viral elements that are
clustered at the interface between pDCs and infected cells
and is regulated by the actin network. Importantly, we
revealed that uncleaved prM surface protein-containing
immature particles play a key function in stimulating the
innate immune response. These non-infectious immature
particles are released by infected cells as a consequence of
a suboptimal cleavage site, which is an evolutionarily
conserved viral feature that likely favors the export of
infectious virus by prevention of premature membrane
fusion in the secretory pathway. Therefore our results
highlight a conceptually novel trade-off between efficient
infectious virus release and the production of IFN-inducing
particles. This concept may have broad importance for the
many viruses that, like DENV, can disable the pathogen-
sensing machinery within infected cells and can release
uncleaved glycoprotein-containing non-infectious parti-
cles.
Immature Dengue Viral Particles Trigger IFN by pDC
PLOS Pathogens | www.plospathogens.org 2 October 2014 | Volume 10 | Issue 10 | e1004434
producer cells were markedly enriched in pDCs, characterized as a
CD123-positive population, as compared to the CD123-negative
population (Figure 2B). For example, 12 hours after co-culture of
DENV infected cells with PBMCs, <0.05% and <25–30% of
CD123-negative and –positive cells, respectively, were IFNa
positive (Figure 2B). Consistently, the frequencies of IFNa
producer cells (i.e., about 30%) among pDCs (i.e., CD123-positive
populations) were comparable in co-cultures of DENV infected
cells with PBMCs vs. isolated pDCs (Figure 2B). Together these
results suggested that IFNa is robustly produced only by pDCs
that are co-cultured with DENV infected cells.
Sensing of cells infected by different members of the
Flavivirus genus by pDCs is not cell-type restricted
Next, we showed that co-cultivation of DENV infected primary
cells, i.e., monocyte-derived macrophages (mo-M) and monocyte-
Figure 1. pDCs robustly produce IFNa in response to DENV infected cells. (A) Quantification of IFNa in the supernatants of PBMCs, pDC-
depleted PBMCs and isolated pDCs (Responders) co-cultured with DENV infected Huh7.5.1 cells (DENV cells) or treated with 100 ml of supernatants
from the latter (DENV SN), as indicated (Inducers). Viral titers of DENV SN <2.56106 foci forming units (ffu)/ml. pDC depletion/enrichment was
performed using an anti-BDCA-4 antibody. Cell #; number of co-cultured responder cells. Cont cells; uninfected Huh-7.5.1 cells. Arrows indicate
results below the detection threshold of the IFNa ELISA (i.e., 12.5 pg/ml). Results are representative of 4 independent experiments. Error bars
represent the means6 SD. (B) Representative FACS analysis of pDC depletion and isolation from PBMCs using the pDC selective markers, CD123 and
BDCA-2. (C) Quantification of IL6 in the supernatants of PBMCs and pDC-depleted PBMCs triggered by LPS (10 mg/mL for 20 hours). Results are
expressed as percentage relative to LPS-treated PBMCs. 3 independent experiments in triplicate (error bars, means 6 SD), paired Student’s t test,
***p,0.0001, NS p.0.1, D; indicates separated group by ANOVA. (D) Total PBMC population containing a number of pDCs equivalent to the purified
pDCs as determined by FACS analysis as described in (B) were co-cultured with DENV infected cells. IFNa productions were thus compared for equal
numbers of pDCs. PBMCs and pDC-depleted PBMCs were compared using equal cell numbers. The results are expressed as IFNa levels relative to the
co-culture with PBMCs, set at 100, 3 independent experiments in triplicate, paired Student’s t test, ***p,0.0001, NS p.0.05, D; indicates separated
group by ANOVA (error bars, means6 SD). (E) Quantification of IFNa secretion by pDCs isolated from the blood of a healthy donor cohort (n = 20) co-
cultured with infected cells or treated with their supernatant. IFNa levels in the supernatants of pDCs co-cultured with uninfected (cont) cells or with
DENV SN were all below the detection threshold (i.e., 12.5 pg/ml).
doi:10.1371/journal.ppat.1004434.g001
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derived dendritic cells (mo-DC) with pDCs (isolated from the same
donor), potently triggered pDC IFNa secretion (Figures 3A and
3B). This stood in stark contrast to the corresponding cell-free
supernatants containing virus or the parental uninfected cells did
not, or very weakly, induced pDC IFNa production (Figures 3A
and 3B). Consistent with the previously reported inhibition of type
I IFN production by the DENV NS2B-3 protease in infected cells
[12,13,14,15], DENV infected primary cells did not produced
detectable levels of IFNa (Figures 3A and 3B).
Additionally, we determined if the production of IFNa by pDCs
could be reproduced in response to co-culture with various cell
types infected by DENV. Robust secretion of IFNa was triggered
when pDCs were co-cultivated with DENV infected cell lines from
different origins (i.e., human Huh7.5.1, Hela and 293T cells or
non-human BHK-21 and Vero cells), but not by the correspond-
ing supernatants containing virus or the uninfected cells
(Figure 3C). DENV infected Vero cells were weaker IFNa
inducers (Figure 3C), consistent with lower levels of intracellular
DENV RNA (Figure 3D) and infectious viral particle (Figure 3E)
produced by these cells, suggesting that pDC IFNa induction is
proportional, to some degree, with the level of viral replication.
Remarkably, 293T cells infected by another member of the
Flavivirus genus, West Nile virus (WNV), but not the correspond-
ing cell-free supernatants containing virus, also triggered robust
IFNa production when co-cultured with pDCs (Figure 3C).
Similar to the results obtained using co-cultures with DENV
infected cells, the pDC IFNa responses increased as the numbers
of WNV infected cells increased (Figures S2B and S2C). Together,
these results demonstrated that the production of IFNa by pDCs
in response to co-culture with DENV infected cells is not cell type
specific and that pDCs similarly respond to another member of the
Flavivirus genus.
Short range sensing of infected cells by pDCs triggers the
IFNa response
Cell-free supernatants containing virus from various infected
cell types failed to trigger pDC IFNa production, even when
added as crude non-filtered supernatants containing virus at
Figure 2. Time course analysis of pDC IFNa production triggered by DENV infected cells. (A) Quantification of IFNa in the supernatants of
PBMCs and pDCs isolated from two different donors (#1 and #2, as indicated) and co-cultured with DENV infected Huh7.5.1 cells (DENV cells) or
treated with 100 ml of supernatant from the latter cells (DENV SN, viral titers <36106 and 16106 ffu/ml for experiments with Donor #1 and #2,
respectively) for the indicated time of incubation. Uninfected Huh-7.5.1 cells are referred to as (cont) cells. Error bars represent the means6 SD, n = 3.
Arrows indicate results below the limit of detection of the IFNa ELISA assay (i.e. 12.5 pg/ml). (B) Quantification of IFNa-positive cells at the indicated
incubation times of PBMCs or pDCs isolated from two different donors (#1 and #2, as indicated) and co-cultured with DENV infected Huh7.5.1 cells
(DENV cells) or treated with 100 ml of supernatant from the latter cells (DENV SN, viral titers of <36106 ffu/ml). The pDC surface marker CD123 and
intracellular IFNa staining were assessed by FACS analysis. Results are expressed as the percentages of IFNa positive cells in CD123 positive- and
negative-populations.
doi:10.1371/journal.ppat.1004434.g002
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concentrations as high as 20 infectious units per pDC (Figure S3),
indicating that the transmission of the immunostimulatory signal
to pDCs likely requires cell-to-cell contacts. To determine if
contacts with DENV infected cells favors pDC sensing, we
assessed IFNa production by pDCs cultured in transwell chambers
with infected cells. Transwell cultures containing DENV infected
monocyte-derived dendritic cells (mo-DCs) and pDCs separated
by a 0.4 mm permeable membrane did not result in detectable
levels of IFNa production by the pDCs (Figure 4A). Similar results
were obtained using DENV infected Huh7.5.1, BHK-21, Hela
and Vero cells as well as WNV infected cells (Figure 4B),
confirming that this feature is not cell type specific or restricted
Figure 3. pDC IFNa secretion is triggered by DENV infected primary cells and is not DENV-restricted. (A–B) Quantification of IFNa in
supernatants of pDCs co-cultured with infected monocyte-derived macrophages (mo-M, DENV) (A) or with infected monocyte-derived dendritic cells
(mo-DCs, DENV) (B) or treated with their supernatant (SN). Error bars represent the means 6 SD. Results are representative of 2 independent
experiments. Insets, time course analysis of intracellular DENV genome equivalent (GE) levels in mo-M (A) and mo-DC (B) post-infection with a MOI of
3. Results are expressed as DENV GE/mg total RNA (means 6 SD, n = 3). (C) Quantification of IFNa in supernatants of pDCs co-cultured with infected
cells (INF cells) or treated with 100 ml of supernatant from the latter cells (INF SN). Cont cells, uninfected parental cells. Arrows indicate results below
the limit of detection of the IFNa ELISA (i.e., 12.5 pg/ml). Error bars represent the means 6 SD (n, independent experiments, in duplicate: Huh7.5.1
cells/DENV, n = 8; BHK-21 cells/DENV, n = 3; Hela cells/DENV, n = 2; 293T cells/DENV, n = 5; Vero cells/DENV, n = 2; 293T cells/WNV, n = 5). Because of
the limited numbers of isolated pDCs, each experiment comprises a part of the panel of cell lines, thus DENV infected Huh7.5.1 cells and their
supernatants were included in each independent experiment (n = 8) and served as a reference to compare and collate results of independent
experiments. Parallel determination of intracellular DENV RNA levels, expressed as DENV GE/mg total RNA (D) and infectious virus production,
expressed as ffu/ml (E).
doi:10.1371/journal.ppat.1004434.g003
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to DENV. Similarly to IFNa, pDCs robustly produced IFNb when
in contact with DENV infected cells, but not when cells were
physically separated by a transwell membrane (Figure 4D).
Consistent with these results, IFNb production by pDCs was not
triggered by supernatants from DENV infected cells and DENV
infected cells did not themselves release detectable levels of IFNb
(Figure 4D). In control experiments using identical transwell
culture settings, an agonist of TLR7, a viral RNA immune sensor
[9], triggered the production of both IFNa and IFNb by the pDCs
at levels similar to those obtained in the co-culture setting
(Figure 4C and 4E), thus ruling out potential non-specific effects of
the experimental setting on pDC responsiveness. In agreement
with previous reports [29,30], vesicular stomatitis virus (VSV) or
Influenza virus (FluAV) containing supernatants robustly triggered
IFNa production by pDCs (Figure 4F). Consistent with these
results, VSV and FluAV infected cells in contact with pDCs
(Figure 4F, cocult) or separated by a transwell membrane
(Figure 4F, TW), triggered IFNa production at similar levels.
This suggested that contact with virus infected cells is not a
universally employed mechanism to promote pDC activation by
RNA viruses. Next, viral transmission across the transwell-
membrane was assessed by quantifying infectious DENV (Fig-
ure 4G) and WNV (Figure 4H) on both sides of the membrane
that separated infected cells from recipient cells. To evaluate the
possible interference of recipient cells on the extracellular
infectivity detection, we compared two types of recipient cells,
i.e., IFNa response-competent pDCs, which are non-permissive to
infection (Figure S4) and permissive cells (Figure 4G and 4H,
Naı¨ve recipient cells). As expected from their size, infectious viral
particles readily flowed across the 0.4 mm membrane (Figures 4G
and 4H), thereby permitting viral transmission from infected cells
to naı¨ve cells in the absence of direct contact (Figures 4I and 4J).
In sharp contrast, type I IFN production by the pDCs was induced
exclusively under conditions where cell-to-cell contact was possible
between infected cells and pDCs (Figures 4A, 4B and 4D).
Collectively, these results demonstrated that the exposure of
pDCs to the DENV or WNV infected cell milieu either at defined
time points (Figure 3A–C) or continuously (Figures 4A, 4B and
4D) failed to trigger a robust IFN response by pDCs, which were
responsive to infected cells by cell-to-cell contact and/or in a short-
range manner.
DENV infected cells transmit viral RNA to pDCs and
induce a TLR7-mediated antiviral state and pDC
maturation
pDCs typically respond to viral infection via endolysosome-
localized TLR7- or TLR9 sensors that recognize RNA or DNA
viral genomes, respectively [9]. Accordingly, we examined the
transmission of DENV RNAs to co-cultured pDCs. The presence
of DENV RNA in infected cells and co-cultured pDCs (selectively
labeled with DiI, a fluorescent membrane dye) was assessed using a
highly sensitive DENV RNA-specific fluorescence in situ hybrid-
ization (FISH) assay (Figure 5A, upper panels). The analyses were
performed after 5 hours of co-culture with DENV infected cells, at
which time pDCs already produced IFNa (Figure 2A). DENV
RNA (green) was detected as discrete dots inside pDCs (Figure 5A,
lower panels). Inspection of consecutive Z-axis sections of co-
cultures stained by combined DENV RNA FISH and anti-IFNa
immuno-detections revealed that the frequency of DENV RNA-
positive pDCs was elevated in both IFNa-positive (i.e., 85%) and
IFNa-negative pDCs (i.e., 74.5%) (Figure 5A, summary table).
The specificity of these examinations was validated by the absence
of DENV RNA-positive pDC when co-cultured with uninfected
cells and when the FISH procedure was performed in the absence
of the DENV RNA specific probe (Figure 5A, summary table and
Figure S5). The presence of DENV RNA in IFNa-negative pDCs
may reflect the time required for DENV RNA to trigger pDCs to
produce enough IFNa to be detectable, which may not have
occurred by 5 hours of co-cultivation. Alternatively, differential
DENV RNA localization in intracellular compartments may
modulate their recognition by innate sensors, and/or potential
subsets of pDCs may be differentially responsive to the DENV
RNA stimulus, in accordance with the maximal detection of about
30% IFNa-positive pDCs at plateau (Figure 2B). Only a few
DENV RNA dots were detected inside pDCs, suggesting that it is
a rare event but sufficient to trigger pDC IFN production.
Together, these results indicated that DENV RNA was readily
transmitted from DENV infected cells to co-cultured pDCs,
supporting the notion that DENV RNA might be recognized by
pDC TLR7. Accordingly, a TLR7 antagonist significantly
inhibited pDC IFNa production induced by DENV infected cells
(Figure 5B). The specificity of this TLR7 antagonist was demon-
strated by the inhibition of IFNa production induced by a TLR7
agonist (R848) but not by a TLR9 agonist (ODN2216)
(Figure 5B). Collectively, these results suggested that DENV
infected cells transfer viral RNA to co-cultured pDCs and trigger
TLR7-dependent IFNa production.
Next, to further define the nature of the pDC-mediated antiviral
state induced by contact with DENV infected cells, we examined
the secretion of the inflammatory cytokines, IL-6 and tumor
necrosis factor (TNF)-a, triggered by activation of the transcription
factor NF-kb, known to transduce antiviral signaling downstream
of TLR7 [1]. TNF-a is known to play a pivotal role in the vascular
leakage syndrome, a hallmark of dengue hemorrhagic fever [18].
Sensing of DENV infected cells, but not their supernatants,
specifically triggered pDCs to produce IL-6 and TNF-a at levels
comparable to those induced by treatment with a TLR7 agonist
(Figure 5C). In addition, ISGs (i.e., MxA and ISG56) were
specifically up-regulated in co-cultures of DENV infected cells
with pDCs or PBMCs (Figure S6), thus indicating the establish-
ment of an antiviral state.
Finally, we determined if DENV infected cells trigger pDC
maturation as assessed by the up-regulation of the CD83 and
CD86 markers at the cell surface. DENV infected cells, but not
their supernatants, triggered a rapid increase in the surface
expression of CD83 on co-cultivated pDCs (i.e., in CD123
marker-gated cells) (Figure 5D, left panel), accompanied by a
slightly delayed augmentation of CD86 cell surface expression
(Figure 5D, left panel) and by a concomitant increase in IFNa
secretion (Figure 5D, right panel). Collectively, these results
demonstrated that sensing of DENV infected cells by TLR7, a
sensor of single stranded-RNA, triggers IFNa production by
pDCs, along with the induction of the inflammatory response, an
antiviral state and pDC maturation.
The IFNa response by pDCs is modulated by DENV
glycoproteins
To define how pDCs sense DENV infected cells, we analyzed
the ability of cells harboring recombinant DENV genomes
containing mutations specifying phenotypes deficient in various
viral functions to trigger IFNa production by co-cultured pDCs.
First, we tested cells containing DENV genomes encoding lethal
mutations in the methyltransferase domain of the viral NS5
polymerase (i.e., Rep2/2) [31]. As expected [31], the triple
mutation significantly reduced the intracellular level of DENV
RNA at 48 hours post-transfection as compared to the wild type
(WT) genome (Figure 6A), reflecting a failure to amplify viral
RNA (Figure S7A). Consistently, this mutant did not express
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Figure 4. pDC IFNa production triggered by DENV and WNV infected cells is cell-to-cell contact-dependent. (A) Quantification of IFNa
in supernatants of pDCs co-cultured with DENV infected monocyte-derived dendritic cells (mo-DCs) either seeded together (coculture) or separated
by a 0.4 mm transwell membrane (transwell). Results are representative of 2 independent experiments in triplicate (means 6 SD). Cont mo-DC;
uninfected mo-DC. (B) Quantification of IFNa in supernatants of pDCs co-cultured with infected cells (INF cells), set-up as in (A). Positions of the pDCs
relative to the transwell membrane are indicated. Error bars represent means 6 SD, n; independent experiments in duplicate: BHK-21 cells/DENV,
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detectable amounts of intracellular viral proteins (Figure S7B).
Despite comparable intracellular viral RNA levels between the
DENV WT and Rep2/2 mutant genomes at the onset of co-
culture i.e., 24 hours post transfection, likely reflecting the input
transfected RNA (Figure 6A), Rep2/2 DENV mutant genome
harboring cells did not trigger IFNa production by co-cultured
pDCs (Figure 6D). Similarly, cells harboring DENV genomes
encoding a four amino acid deletion in the capsid (i.e., amino acids
V51-to-L54), that significantly compromised both viral RNA
replication (Figures 6A and S7A) and viral protein expression
(Figure S7B), failed to induce IFNa production by co-cultured
pDCs (Figure 6D). Together these results indicated that the pDC
IFNa response requires active viral replication in neighboring
DENV infected cells.
Next, to address the requirement of viral genome release for
pDC activation, we tested the effects of co-culture with cells
harboring DENV genomes encoding point mutations in the
envelope (E) glycoprotein, i.e., the substitutions D215A, H244A or
P217A, known to inhibit infectious viral production [32,33].
Consistent with previous reports [32,33], the E glycoprotein
mutations did not impair intracellular levels of either viral RNAs
or proteins (Figures 6A, S7A and S7B), but they all greatly
compromised the production of infectious particles (Figure 6B).
Both the D215A and H244A mutations abrogated the release of
viral RNA and structural proteins and the pDC IFNa response
(Figures 6C–D and S7C). Conversely, cells harboring DENV
genomes encoding the P217A mutation triggered the IFNa
response by pDCs (i.e., <36% relative to WT) (Figure 6D) at
various inducer cell concentrations (Figure S7D) and in proportion
to the release of extracellular DENV RNA (i.e., <60% and 26%
relative to WT at 24 and 48 hours post-transfection, respectively)
(Figure 6C) and viral structural proteins (Figure S7C). Remark-
ably, the production of infectious virus (Figure 6B) was severely
and disproportionally inhibited by the P217A mutation (i.e., 40-to-
1,000 fold-reduction at 24-to-48 hours post-transfection) as
compared to the modest inhibition of the IFNa response by
pDCs (i.e., <2.5 fold-reduction of IFNa response in the same time
period) (Figure 6D and S7D). These results suggested that
infectious virus production is not required and/or is not rate-
limiting for pDC activation. Consistently, pDCs were not
permissive to DENV infection (Figure S4A), this latter observation
is in line with the previous demonstration of pDCs as refractory to
infection by other viruses [30,34,35].
Altogether, these results suggested that glycoprotein-dependent
release of non-infectious viral components by DENV infected cells
might trigger the IFNa response by contacting pDCs.
DENV envelope protein-dependent transfer and
activation of IFNa response by pDCs
To determine whether DENV surface proteins mediate the
transmission of viral components to pDCs, we first assessed
whether, similarly to DENV RNA (Figure 5A), the DENV
envelope proteins are transmitted into the pDCs, by inspection
of consecutive Z-axis sections of DiD-labeled pDCs in co-culture
with cells harboring the WT and DENV genomes encoding E
protein mutations (Figure S8). Similar to DENV genome, we
observed the E glycoproteins (E GP) in dot-like structures inside
the pDCs. The frequencies of E GP dot-positive pDCs were
elevated when in the co-cultures with either cells harboring the
WT genome (i.e., around 90%) or the P217A mutation (i.e., above
65%) (Figures 6E and S8), which was in proportion to the release
of extracellular DENV RNA (i.e., 60% relative to WT particles at
24 hours post-transfection) (Figures 6C). In contrast, cells harbor-
ing the DENV genome encoding the H244A mutation in E, which
do not release viral particles and fail to trigger the IFN response by
pDCs (Figures 6B, 6C, 6D, S7C and S7D), demonstrated little to
no transmission of the E GP into the pDCs (Figures 6E and S8).
Because the intracellular levels of viral components (i.e., viral
RNA, E and capsid proteins) were equivalent for cells harboring
DENV genomes encoding the H244A point mutant, as compared
to WT genome (Figures 6A and S7B), the results suggested that
pDC IFNa production is activated by the glycoprotein-mediated
transmission of viral components from DENV infected cells into
contacting pDCs.
Next, we tested the impact of expressing the DENV surface
proteins alone (Figure S9A) on pDC IFN induction. Expression of
the envelope proteins alone is known to result, in absence of
nucleocapsid, in the release of viral envelope containing-
membrane vesicles, the sub-viral particles (SVPs) (Figure S9B)
[36]. Although the glycoproteins were readily transmitted from
cells expressing only the DENV surface proteins to the co-cultured
pDCs (Figure S9D–F), IFNa production was not triggered (Figure
S9C). These observations are in agreement with the transmission
of DENV RNA to pDCs and activation by the TLR7 RNA sensor
(Figure 5A and 5B).
To corroborate these results, we determined whether pDC
activation by contact with DENV infected cells requires an
internalization-dependent mechanism by testing inhibitors of
dynamin (Dynasore) [37], of clathrin-mediated endocytosis
(Chlorpromazine [38]) and of macropinocytosis (Go¨6983-PKC
inhibitor [39,40]). Inhibitors of both dynamin and clathrin-
mediated endocytosis, but not macropinocytosis, abrogated pDC
IFNa production triggered by DENV infected cells (Figure S10A),
without any effect on the ongoing DENV replication and viral
production (Figures S10B–C). In addition, these inhibitors did not
markedly impair pDC IFNa production induced by a TLR7
agonist (Figure S10A), a cell-permeable imidazoquinoline, which
passively diffuses inside the pDCs [41], thus ruling out potential
side-effect downstream of TLR7 recognition. These results, in
agreement with the requirement of the endolysosome localized-
sensor, TLR7 (Figure 5B), suggested that pDC IFNa production
triggered by DENV infected cells requires glycoprotein-mediated
n = 4; Hela cells/DENV, n = 2; Vero cells/DENV, n = 2; 293T cells/WNV, n = 2. Huh7.5.1 cells/DENV were included in each independent experiment (n = 5)
as a reference. Cont cells; uninfected parental cells. (C) Quantification of IFNa in supernatants of pDCs triggered by a TLR7 agonist (R848, 50 ng/mL),
set-up as in (A) (means 6 SD, n = 5). (D–E) Quantification of IFNb in supernatants of pDCs co-cultured with DENV infected Huh7.5.1 cells (DENV cells)
(D) or triggered by TLR7 agonist (E), set-up as in (A) (means 6 SD, n = 3). (F) Quantification of IFNa in supernatants of pDCs co-cultured with cells
infected, or not (-) by either DENV, vesicular stomatitis virus (VSV) or influenza A virus (FluAV), set-up as in (A). Cocult; co-culture, TW; transwell
membrane set-up. pDCs or naı¨ve cells (indicated as Huh) were exposed to the supernatants of infected cells (SN) (means 6 SD, n = 3). (G–H) Results
of viral titers of DENV (G) and WNV (H) in supernatants harvested from the two sides (top or bottom) of the transwell membrane (means 6 SD, 2
independent experiments in duplicate). Positions of the infected cells in reference to the transwell membrane (top or bottom), which separates them
from naı¨ve recipient cells or pDCs, are indicated. (I–J) Quantification of intracellular DENV RNA levels (I) and percentage of WNV-GFP positive cells (J)
in infected donor cells and co-cultured naı¨ve recipient cells separated by the transwell membrane (means 6 SD, 2 independent experiments in
duplicate). Parallel infection of 293T cells with supernatant (SN, MOI = 4) serves as a reference for the expected level of WNV-GFP expression at
20 hours post-inoculation (means 6 SD, n = 2).
doi:10.1371/journal.ppat.1004434.g004
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secretion of non-infectious viral components, which are subse-
quently internalized by co-cultured pDCs. These results demon-
strated that pDC activation triggered by DENV infected cells is
distinct from that induced by cells infected by other viruses, such
as HCV, LCMV and classical swine fever virus (CSFV), which
does not require viral structural protein expression [4,5,7].
Disruption of cell contact and DENV surface protein
clustering by cytoskeleton inhibitors abrogates the pDC
IFNa response
Next, we sought to study the regulation by cell contacts of
DENV surface protein-dependent transfer and activation of pDCs.
First, the cytoskeleton organization at the cell interface between
pDCs and DENV infected cells was determined by confocal
microscopy analysis. We observed an accumulation of the actin
network at the cell contacts (Figure 7A–E), while the microtubule
network was not markedly modified at this location (Figure S11A,
left panel). In agreement with the importance of secreted structural
components for pDC activation (Figure 6), specific immunostain-
ing of non-permeabilized cells revealed that envelope proteins (i.e.,
E GP and prM) were both present as clusters at the interface
between pDCs and infected cells (Figures 7F–Q and S12).
These observations prompted us to define the impact of the
cytoskeleton network on cell contact-dependent pDC IFNa
production. We showed that two inhibitors of the cytoskeleton
network, Latrunculin B and Nocodazole (i.e., actin and microtu-
bule depolymerizing drugs, respectively) disrupted the actin
network in co-cultures of pDC/DENV infected cell (Figure 8A),
consistent with previous reports [42,43]. As expected, the
microtubule network was only perturbed by Nocodazole treatment
(Figure S11A) [44]. By imaging flow cytometry analysis of GFP
expressing-DENV infected cells co-cultured with pDCs (stained by
pDC marker CD123) (Figures S13), we showed that the frequency
of conjugates between pDCs and DENV infected cells was greatly
decreased by inhibitors of the cytoskeleton network (Figure 8B and
S13). Both these inhibitors, in conjunction with the loss of actin
accumulation at the contacts (Figure 8A), impaired E glycoprotein
clustering (Figure 8C). Indeed, quantifications performed in a
‘‘double-blind’’ set-up revealed that, while E GP clustering was
readily observed at the cell interface in untreated co-cultures (i.e.,
<60% of the pDCs at close proximity with DENV infected cells
harboring E GP clustering), these frequencies were reduced to
15% for co-cultures treated with either inhibitor (Figure 8D).
Importantly, similar treatments inhibited IFNa production by the
pDCs (Figure 8E). Neither compound inhibited DENV RNA
replication in the infected cells and infectious viral production
(Figures 8F–G), nor did they prevent the internalization ability of
pDC, as assessed by membrane dye uptake (Figure S11B). In
addition, they did not inhibit pDC IFNa production triggered by a
TLR7 agonist (Figure 8E), thus ruling out potential nonspecific
effects of these compounds on pDC responsiveness.
Altogether, these results suggested that the cytoskeleton-
dependent regulation of cell contacts and apposed GP clustering
likely favors the subsequent activation of IFNa production by the
pDCs.
Cell producing immature DENV particles trigger pDC
IFNa production more potently than cells releasing
mature virus
The phenotypic analysis of a virus production defective mutant
(i.e., P217A) (Figure 6) revealed that infectious virus production is
not required and/or is not rate-limiting for pDC activation.
Like many viruses, DENV infected cells release immature non-
infectious particles harboring uncleaved precursor membrane
proteins (prM), that are generated by inefficient cleavage of prM
by the resident trans-Golgi protease furin [21,22,23,24,25,26]. To
determine whether immature particles can serve as vehicles from
DENV infected cells to contacting pDCs, we first determined the
presence of prM protein dots inside co-cultured pDCs by using an
antibody recognizing the pr peptide [45] and by examining
consecutive Z-sections by confocal microscopy analysis. Dots of
prM were observed inside pDCs co-cultured with DENV infected
cells (Figures S14A and S14C) with very little background staining
in pDCs co-cultured with uninfected control cells (Figures S14B
and S14C), suggesting that prM (and/or pr peptide), along with
the E GP (Figures 6E, S8 and S9) are readily transferred to the
pDCs.
Next, to determine the ability of immature particles to convey
immunostimulatory RNAs to pDCs, we tested the effects of
DENV genomes encoding mutations in the furin cleavage site of
the prM protein (i.e., the substitutions R88A, K90A and R91A),
which, as expected from previous reports with single mutations
[26], failed to produce infectious virus (Figure 9C). By contrast,
RNA replication, intracellular viral protein expression (Figur-
es 9A, S7A and S7B), release of viral components (Figures 9B and
S7C), and transmission of viral components to the pDCs
(Figures 9D and S8D) were maintained at levels comparable to
the WT counterparts. Remarkably, the pDCs produced similar
levels of IFNa when comparing contacting cells producing non-
infectious immature virions vs WT DENV (Figure 9E). Similar
results were obtained when using various concentrations of cells
harboring WT/mutant DENV genome (Figure S7D). Therefore,
these results suggested that cells producing immature particles
potently trigger IFNa production by contacting pDCs.
Next, to define the specific function of uncleaved prM-
containing particles in pDC activation by DENV infected cells,
Figure 5. Recognition and pDC antiviral signaling triggered by DENV infected cells. (A) DENV RNA is transferred from infected cells to
pDCs. Upper panels, projections of confocal microscopy analysis of DENV RNA (green) detected by FISH in DENV infected Huh-7.5.1 cells (DENV cells/
no pDC) and in pDCs after 5 hours of co-culture with uninfected cells (cont cells/pDCs) or with DENV infected cells (DENV cells/pDCs), pDC DiI dye
(red), IFNa protein (white) and nuclei (blue). Lower panels, consecutive Z-axis sections and 3D reconstitutions with magnification of the yellow-boxed
pDC. Cell contours on the DENV RNA panels labeled with dotted lines surrounding DiI staining. Yellow arrows; DENV RNA dots inside pDC, *; pDC and
#; Huh7.5.1 cells. Summary table, percentages of IFNa-positive- or negative-pDCs (green colored lines) that contain DENV RNA after co-culture with
DENV cells, control cells or DENV cells with FISH procedure performed in absence of DENV probe (no probe), as controls. Similar results were obtained
in 3 independent experiments, # cells; numbers of cells included in the analysis. (B) Quantification of IFNa in the supernatants of pDCs that were
preincubated, or not, with TLR7 antagonist (IRS661, 0.35 mM), as indicated, then co-cultured with DENV infected Huh7.5.1 cells (DENV cells) or
stimulated by TLR7 agonist (R848, 50 ng/mL) or TLR9 agonist (ODN2216, 0.1 mM) [1]. Results are expressed as the percentages of IFNa produced in
the absence of TLR7 antagonist (means6 SD, n = 4, paired Student’s t test: *, p,0.01). (C) Quantification of TNFa and IL6 in supernatants of pDCs co-
cultured with DENV cells, treated with DENV SN (viral titers<26106 ffu/ml) or TLR7 agonist, set-up as in (B) (means6 SD, n = 2 for IL6, n = 3 for TNFa).
Arrows indicate results below the limit of detection (TNFa and IL6, 8 and 25 pg/ml, respectively). (D) Left panel, quantification of surface CD83 and
CD86 on CD123-gated cells by FACS analysis at the indicated times, set-up as in (B), Right panel, parallel quantification of supernatant IFNa (means6
SD, n = 3).
doi:10.1371/journal.ppat.1004434.g005
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Figure 6. Viral functions required for pDC IFNa production triggered by DENV infected cells. The impact of mutations in NS5 (Rep2/2,
substitutions G81A, G83A and G85A), capsid (DV51–54, deletion V51-to-L54) and E (substitutions D215A, H244A or P217A) on the levels of
intracellular DENV RNA (A), infectious virus production (B), extracellular DENV RNA (C) analyzed at the indicated times post-transfection of WT and
mutant DENV genomes and quantification of IFNa secretion by pDCs co-cultured with cells harboring the WT and mutant DENV genomes (D), control
cells (-). GE; genome equivalent. In D, cells harvested at 24 hours post-transfection were co-cultured with pDCs for 20 hours. Results of 3 independent
experiments in triplicates are expressed as percentages relative to the WT DENV genome. Error bars represent the means 6 SD, paired Student’s t
test, *p,0.05, **p,0.01. Triangles indicate the mutants (i.e., Rep2/2 and DV51–54) that belong to a separated group, statistically different from the
WT and the other mutants of the panel in regards to the intracellular DENV GE levels at 48 hours post-transfection using a non-parametrical analysis
(ANOVA). Arrows indicate results below the limit of detection of RT-qPCR: 20 intracellular DENV GE/mg total RNA and 30 extracellular DENV GE/ml;
infectious titers: 20 ffu/ml and IFNa ELISA: 12.5 pg/ml. (E) DENV E GPs are transferred from cells harboring the WT and mutant DENV genomes to
Immature Dengue Viral Particles Trigger IFN by pDC
PLOS Pathogens | www.plospathogens.org 11 October 2014 | Volume 10 | Issue 10 | e1004434
we designed experiments aiming at modulating the levels of prM
maturation. Firstly, we assessed the impact of an inhibitor of furin.
As expected, this inhibitor markedly decreased the maturation of
DENV particles, as shown by an increased prM:E ratio measured
by ELISA (Figure 9F). The production of extracellular infectious
DENV was also reduced in a dose-dependent manner upon furin
treatment (Figure 9H), while the levels of intracellular DENV
RNA were unchanged (Figure 9G). Remarkably, inhibition of
prM cleavage enhanced IFNa productions by co-cultured pDCs in
a dose-dependent manner (Figure 9I). Increased pDC activation
was observed despite a reduction in the release of physical
particles, as shown by extracellular DENV RNA measurement
(Figure 9H). Altogether these results suggested that the activation
of pDCs triggered by contacting infected cells inversely correlates
with the levels of prM maturation.
To further confirm these results, we studied the impact of furin
up-regulation. As expected, cells overexpressing furin produced
viral particles containing reduced prM:E ratios (i.e., <10-fold
reduction) (Figure 9J). The specific infectivity of DENV particles
was increased upon furin overexpression (i.e., <3-fold increase in
the ratios of infectivity to extracellular DENV RNA, comparing
furin-overexpressing cells to counterpart control cells). Thus, cells
overexpressing furin were compared to counterpart cells that
produced either similar levels of intracellular and/or extracellular
DENV RNA, or alternatively, similar production of infectious
virus, by using different MOIs (Figure 9K–L). Our results
indicated that cells producing more mature particles were clearly
impaired at triggering IFNa production by co-cultured pDCs
(Figure 9M).
Altogether these results demonstrated that cells producing
immature DENV particles are very potent at inducing IFNa
production by pDCs, as compared to cells releasing mature
virions.
Discussion
DENV has rapidly emerged in recent years as the most
significant arboviral disease of humans, with greater than half of
the world population at risk of infection [46]. Despite many years
of research, the virus–host interactions that determine dengue
pathogenesis are still incompletely understood [47]. Nonetheless,
the self-limiting febrile symptoms observed in most DENV-
contracted cases and the short course of illness suggest a key role
for innate immune defenses in controlling DENV infection at early
stages [18]. Accordingly, in vivo studies have demonstrated a
critical role for type I IFNs in the host defense against DENV
[16,18,19]. Furthermore, the activation of pDCs strongly corre-
lates with the disease outcome of DENV infected patients [48].
Importantly, a study of children with DENV infections across a
broad range of illness severities suggested that a blunted blood
pDC response to systemic infection was associated with higher
viremia levels and was a key step in the pathogenic cascade toward
severe disease [49]. Although the activation mechanism and exact
function are still elusive, altogether, these findings highlight the
critical roles played by pDCs and the IFN response on disease
progression in DENV infected individuals. Here, we revealed that
DENV infected cells potently trigger IFNa secretion by non-
permissive pDCs, a host response that bypasses the evasion
from the innate response within infected cells. Furthermore, we
demonstrated that TLR7-dependent IFNa production by pDCs in
response to infected cells is concurrent with other hallmarks of
innate immunity, such as inflammatory cytokine secretion, ISG
up-regulation and pDC maturation.
In agreement with our results, Rodriguez at al. showed that
DENV-containing supernatants failed to trigger pDC IFNa
production [50], while other reports suggested that they triggered
pDC activation [48,51]. This discordance may be explained by the
preparation and concentration of supernatants and large number
of pDCs that were used in the latter reports. Remarkably, the
results of our study demonstrated that, despite continuous
exposure to the infected cell milieu, physical separation from
infected cells precludes the IFN response by pDCs. Consistently,
strong pDC IFNa secretion was induced by co-cultured DENV
infected cells (i.e., up to 0.5 mg/ml), indicating that cell-to-cell
contact is a key feature of pDC activation. Interestingly, cell-to-cell
transmission of immunostimulatory signals appears to be a
common characteristic of pDC induction, as shown in this report
for two members of the Flavivirus genus, DENV and WNV and
as previously reported for other viruses, i.e. HCV, HIV, LCMV
and CSFV [3,4,5,6,7]. Specifically, our previous results obtained
in the context of HCV indicated that pDC stimulation occurs via
viral RNA-containing exosomes. In this context, we suggested that
the concentration of immunostimulatory exosomes in the super-
natants was below an activating threshold for pDC stimulation,
while this threshold might be reached in the intercellular space
when cells are in contact [3].
Importantly, we showed here that viral structural components
are detected in clusters at the interface between pDCs and infected
cells. This finding suggests that cellular surface molecules and/or
structures might concentrate the PAMP-carrier at the cell contacts,
thereby enhancing transmission to pDCs. We further revealed that
the actin network is pivotal for both this clustering of viral
components at the pDC-infected cell interface, likely by regulating
cell-to-cell contacts, and for pDC activation. Based on this
observation, it is conceivable that the cytoskeleton structure serves
as a platform contributing to the cell-to-cell transmission of viral
components to the pDCs. Additional experiments will be required
to test these hypotheses and to determine whether, for the various
viruses that trigger the pDC IFN response in a cell-to-cell contact
dependent manner, the mechanism of activation involves either
common or distinct cellular factors and/or structures at the
contacts.
The mechanism we have identified is distinct from the
conventional induction of the innate response, which typically
occurs by the recognition of viral nucleic acids within infected cells
[1,2]. Moreover, in contrast with the previously characterized
induction of pDC IFNa production through contact with infected
cells [3,4,5,7], here we have defined a sensing pathway, which
requires an E glycoprotein-dependent secretion of viral compo-
nents, notably viral RNA, to trigger the pDCs. As such, it is
different from the mechanism of induction by cells infected by
other viruses, which does not require viral structural proteins
[3,4,5,7]. Indeed, our results illustrate the crucial role of DENV
envelope proteins in the induction of the innate response by
neighboring IFN producer pDCs that are not permissive to
infection. Importantly, our results revealed that cells producing
uncleaved prM-containing immature particles triggered IFNa by
pDCs more potently than cells efficiently producing fully mature
pDCs in co-cultures for 8 hours. Results are expressed as the percentages of DiI stained pDCs that contain E GP dot(s) detected by immunostaining
and analyzed by confocal microscopy. Representative pictures are displayed in Figure S8. Similar results were obtained in 3 independent experiments
and <20 pDCs surrounded by E GP positive/DiI negative cells were observed per experimental condition.
doi:10.1371/journal.ppat.1004434.g006
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virions. These immature particles are known to be deficient for the
membrane fusion step, which occurs in the endo-lysosomal
compartment during cell entry [52,53,54]. Interestingly, recogni-
tion of viral RNA by TLR7 sensor also takes place in this cellular
compartment [1,55]. Therefore, based on these findings, we
suggest a working model in which an extended retention within
the endosomal compartment of fusogenic-deficient immature
particles may favor the exposure of their viral genome for TLR7
recognition. In contrast, mature virions, which are fusion-
competent, could escape from this compartment by membrane
fusion. Additional experiments will be required to firmly validate
and generalize this new concept.
Several reports have demonstrated that a large proportion of
uncleaved prM-containing immature particles are released from
DENV infected cells, i.e., 30-to-40% of viral particles
[21,22,23,24,25,26], on which prM content is variable on a per-
particle basis [56,57]. Consistently, we showed that furin
overexpression reduced the levels of immature virus, otherwise,
produced by DENV infected cells, and concomitantly with
reduced pDC IFN response. Although direct proof is still required,
current evidence supports the in vivo existence of uncleaved prM-
containing virus. Previous studies have demonstrated that a
proportion of B cells isolated from DENV infected individuals
produces monoclonal antibodies against prM [58,59]. In addition,
the characterization of these anti-prM antibodies indicated that
they are a major component of the serological response to DENV
infection, leading to increased replication in Fc receptor-bearing
cells via antibody-dependent enhancement (ADE) [56,58,60].
Importantly, our results illustrate a previously unsuspected
function of these immature particles in innate immunity in
mediating an IFN response by non-permissive bystander pDC.
Indeed, the results of our study imply that the suboptimal furin-
cleavage sequence, likely evolutionarily conserved to favor efficient
export of infectious virus by preventing premature membrane
fusion in the secretory pathway and cell entry of immature virus
into Fc-receptor-expressing cells by ADE [21,22,23,27,28], might
also, by producing an IFN-inducer, contribute to regulate dengue
pathogenesis. It is possible that pDC activation by infected cells
elicits a strong local innate response that may lead to viral
replication suppression or, alternatively, to the possible subsequent
recruitment of DENV permissive cells and systemic viral spread. It
is also conceivable that the interplay between pDCs and other cells
regulating the innate responses, in turn, modulates this newly
identified innate sensing mechanism of infected cells and/or the
homing of pDCs to the infection site.
Productive infection of cells with a wide range of enveloped
viruses depends critically on the processing of the viral surface
glycoproteins by cellular proteases [20]. Yet, depending on viral
variants/strains, such cleavages might be limited by the differential
requirement for certain host proteases, as their expression can be
tissue-restricted. These selective requirements may contribute to
their virulence, as proposed for influenza virus [61]. Additionally,
suboptimal cleavage sites are evolutionarily maintained by
sequence features, such as, e.g., the presence of acidic residues
or glycosylation sites adjacent to the cleavage site [23,62]. These
events lead to the release of viral particles with uncleaved
glycoproteins, as shown for viruses such as, e.g. measles virus
[63], influenza virus [61,64], DENV and WNV [53,56]. Therefore
our results, by uncovering a functional role of immature viral
particles in innate immunity, may have broad implications for our
understanding of the host-virus relationship.
Materials and Methods
Biological materials
Huh-7.5.1 [65], Vero E6 (ATCC CRL-1586), Hela (ATCC
CCL-2) and HEK-293T (ATCC CRL-1573) cells were main-
tained in Dulbecco’s modified Eagle medium (DMEM) (Life
Technologies) supplemented with 10% FBS, 100 units (U)/ml
penicillin, 100 mg/ml streptomycin, 2 mM L-glutamine and non-
essential amino acids (Life Technologies) at 37uC/5% CO2. BHK-
21 cells (ATCC CCL-10) were maintained in Eagle’s MEM (Life
Technologies) with the same supplements. pDCs were isolated
from 450 ml of blood from healthy adult human volunteers which
was obtained according to procedures approved by the ‘‘Etablisse-
ment Franc¸ais du sang’’ (EFS) Committee. PBMCs were isolated
using Ficoll-Hypaque density centrifugation. pDCs were positively
selected from PBMCs using BDCA-4-magnetic beads (MACS
Miltenyi Biotec) and cultured as previously described [3].
Monocytes were positively selected from pDC-depleted PBMCs
using CD14-magnetic beads (MACS Miltenyi Biotec) according to
the manufacturer’s instructions, with a typical purity of 95% of
CD11c-positive cells. CD14+ cells were then differentiated to
monocyte-derived DCs (mo-DCs) by incubation for 6 days in
RPMI 1640 medium supplemented with 10% FBS, 100 U/ml
penicillin, 100 mg/ml streptomycin, 2 mM L-glutamine, non-
essential amino acids, 1 mM sodium pyruvate and 0.05 mM
bmercaptoethanol (Sigma-Aldrich) with 500 U/ml human gran-
ulocyte-macrophage colony-stimulated factor (GM-CSF) and
2,000 U/ml human interleukin 4 (IL-4) (MACS Miltenyi Biotec),
as previously described [12]. To generate monocyte-derived
macrophages, monocytes were cultured in the same medium as
for the mo-DCs with 500 U/ml GM-CSF for 6 days.
Reagents
The antibodies used for immunoblotting were mouse anti-E
glycoprotein (4G2 and 3H5) kindly provided by P. Despres
(Pasteur Institut, Paris, France); mouse anti-capsid (6F3) kindly
Figure 7. Accumulation of actin network and clustering of DENV surface protein at the cell contacts. (A–E) Imaging of the actin network
in co-cultures of pDCs and DENV infected Huh7.5.1 cells (8 hour-incubation). (A) Confocal microscopy analysis of actin stained with CF488A-
conjugated phalloidin (green), IFNa detected by immunostaining (purple) and nuclei stained with Hoechst (blue). (B–E) Magnification of yellow-
boxed pDC/DENV infected cell contact, shown in (A). (B) 3D reconstitution. (C) Confocal microscopy analysis of actin projected on the phase contrast
imaging. (D) Z-axis projection corresponding to the blue line, shown in (A). (E) Color-coded image to represent fluorescence intensity with gradient
indicating the intensity from weak (blue) to strong signal (white). Similar results were obtained in 3 independent experiments. Star mark (*): pDCs and
hash mark (#): Huh7.5.1 cells. (F–K) Imaging of DENV E glycoprotein (E GP) clustering at cell contacts between pDC and DENV infected cells (co-
cultures for 8 hours). (F) Confocal microscopy analysis of with actin (green), pDCs stained with DiI membrane dye (red), E GP (purple,
immunodetection without permeabilization step) and nuclei (blue). (G) Confocal microscopy analysis of E GP-nuclei projected on the phase contrast
imaging. (H–K) Magnification of yellow-boxed cell contacts, shown in (F). (H) Actin-E GP detection. (I) E GP projected on phase contrast. (J) Z-axis
projection corresponding to the blue line in (F). (K) 3D reconstitution. Similar results were obtained in 3 independent experiments. (L–Q) Imaging of
DENV prM clustering at cell contacts between pDC and DENV infected cell in co-culture for 8 hours. (L) Confocal microscopy analysis of prM (green,
immunodetection without permeabilization step), DiI-stained pDC (red) and nuclei (blue). (M) Confocal microscopy analysis of prM-nuclei projected
on the phase contrast imaging. (N–Q) Magnification of yellow-boxed cell contacts, shown in (L). (O) prM staining projected on phase contrast. (P) Z-
axis projection corresponding to the blue line in (L). (Q) 3D reconstitution. Results are representative of 3 independent experiments.
doi:10.1371/journal.ppat.1004434.g007
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Figure 8. pDC IFNa production triggered by DENV infected cells is modulated by actin cytoskeleton network. (A) Imaging of actin
network in co-cultures of pDCs and DENV infected cells treated, or not (control), with cytoskeleton inhibitors (Latrunculin B and Nocodazole, 1 mM).
Upper panels, confocal microscopy analysis of actin (green), DiI-stained pDC (red, *) and nuclei (blue). # indicates Huh7.5.1 cells. Lower panels,
magnification of yellow-boxed cell contacts with actin-DiI (Left) and phase contrast (Right). Representative of 3 independent experiments. (B)
Quantification of the conjugates between CD123-stained pDCs and GFP-expressing DENV infected Huh7.5.1 cells analyzed by imaging flow
cytometry in co-cultures treated with inhibitors as in (A). Results are expressed as percentages of pDC/DENV cell conjugates i.e., conjugates of at least
one cell solely CD123+ and one cell GFP+, relative to the total number of single cells (GFP+ or CD123+) and the conjugates, 2 independent
experiments (exp #1 and #2). Summary table, number of recorded conjugates in each individual experiment. (C) Imaging of E GP clustering in co-
cultures treated as in (A). Upper panels, confocal microscopy analysis with actin (green), DiI-stained pDC (red), E GP (purple, immunodetection
without permeabilization step) and nuclei (blue). Lower panels, magnification of yellow-boxed cell contacts with actin-E GP (left) and phase contrast
(right). (D) Quantification of E GP clustering at the pDC/DENV infected cell interface. Results are expressed as percentages of pDCs with E GP
clustering at the interface with DENV infected cells relative to the total number of pDCs. pDC included in the analysis were in close proximity to E
GP+/DiI- Huh7.5.1 cells. Similar results were obtained in 3 independent experiments, <20 pDCs observed per experimental condition by two blind
visual examinations. (E) Quantification of IFNa in the supernatants of pDCs triggered by co-cultured DENV infected Huh7.5.1 cells (DENV cells) or by
TLR7 agonist. Co-cultures were treated with inhibitors as in (A). Results are expressed relative to IFNa produced in the absence of inhibitor, set to 100
(means 6 SD, n = 4; paired Student’s t test: ***, p,0.0001). Results of intracellular DENV RNA levels (F) and infectious virus production (G) by DENV
infected cells treated as in (A) relative to levels in the absence of inhibitor, set to 100 (means 6 SD, n = 4).
doi:10.1371/journal.ppat.1004434.g008
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Figure 9. Comparison of pDC IFNa production triggered by mature versus immature DENV particles. (A–E) The impact of mutations in
prM (substitutions R88A, K90A and R91A) on the levels of intracellular DENV RNA (A), extracellular DENV RNA (B) infectious virus production (C),
transmission of E GP from cells harboring the WT and mutant DENV genomes to pDCs (D) and quantification of IFNa secretion by pDCs (E) analyzed
as described in the legend of Figure 6. Results of 3 independent experiments in triplicates are expressed as percentages relative to the WT DENV
genome (error bars represent means 6 SD). (F–I) The impact of a furin inhibitor, at the indicated concentrations, on the prM:E ratios in extracellular
viral supernatants detected by ELISA (F), levels of intracellular DENV RNA (G), extracellular DENV RNA and infectious virus production (H), and
quantification of IFNa secretion by pDCs triggered by co-cultured with DENV infected cells or incubation with TLR7 agonist (R848 at 50 ng/mL) (I).
Results are expressed relative to the untreated cells (-), set at 100 (error bars represent the means6 SD, 3 independent experiments in triplicates). (J–
M) The impact of furin overexpression, or not (-), in 293T cells infected by DENV at different MOIs, as indicated. The panels are displayed as in (F–I),
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provided by J. Aaskov (Queensland University of Technology,
Brisbane, Australia); mouse anti-actin (AC74, Sigma Aldrich). The
antibodies used for immunostaining were mouse PE-conjugated
anti-CD123, mouse APC-conjugated anti-BDCA-2, mouse APC-
conjugated anti-IFNa (MACS Miltenyi Biotec), mouse PerCP-
conjugated anti-CD83 (eBioscience), and mouse APC-conjugated
anti-CD86 (BD Bioscience), mouse anti-DENV prM (clone DM-1,
Abcam), mouse anti-alpha tubulin (DM1A, Sigma Aldrich); Ficoll-
Hypaque (GE Healthcare Life Sciences); LPS, TLR7 agonist
(R848) and TLR9 agonist (ODN2216) (Invivogen); TLR7
antagonist, IRS661 (59-TGCTTGCAAGCTTGCAAGCA-39)
synthesized on a phosphorothionate backbone (MWG Biotech);
Fc Blocking solution (MACS Miltenyi Biotec); Golgi-Plug and
permeabilization-wash solution (BD Bioscience); IFNa and IFNb
ELISA kit (PBL Interferon Source); IL-6 and TNFa ELISA kit
(Affymetrix, eBioscience); Lipofectamine 2000 (Life Technologies);
96-well format transwell chambers (Corning); LabTek II Chamber
Slide System, 96-Well Optical-Bottom Plates and Nunc UpCell
96F Microwell Plate (Thermo Fisher Scientific); CF488A-conju-
gated phalloidin (Biotium); Vibrant cell-labeling solution (CM-DiI,
Life Technologies); Hoescht and Alexas-conjugated secondary
antibodies (Life Technologies); iScript cDNA synthesis kit (Biorad),
qPCR kit (Life Technologies). Latrunculin B, nocodazole,
chlorpromazine, dynasore and Go¨6983-PKC were purchased
from Sigma-Aldrich.
Preparation of viral stocks and infection
Viral stocks of the prototypic DENV-2 strain New Guinea C
(NGC) (AF038403) were produced using in vitro RNA transcripts
prepared from DENV-2 infectious plasmid clone pDVWS601
plasmid [66] linearized with XbaI and using mMESSAGE
mMACHINE T7 Kit (Ambion). In vitro transcribed RNA was
introduced into BHK-21 cells by electroporation as previously
described [31]. Briefly, 5 mg of in vitro transcribed RNA was used
to transfect 46106 cells by electroporation. Six hours post-
transfection, the culture medium was refreshed. Virus containing
supernatants collected at 3 days post-electroporation were clarified
through a 0.45 mm filter (Corning).
Viral stocks of WNV (lineage II, strain 956 D117 3B) [67]
were produced by transfection of 26106 HEK-293T cells with
4 mg of the plasmid pWNII-GFP [67] using the Lipofectamine
2000 transfection reagent (Invitrogen) in optiMEM. Six hours
post-transfection, the medium was refreshed with HEK-293T
culture medium. Virus containing supernatants collected 48 h
post-transfection were clarified through a 0.45 mm filter
(Corning).
Viral stocks of vesicular stomatitis virus (VSV-GFP, infectious
titer of <109 Tissue Culture Infectious Dose (TCID50)/ml) were
produced as previously described [68] and kindly provided by Dr
J. Perrault (Department of Biology, Center for Microbial Sciences,
San Diego State University, CA, US). Viral stocks of Influenza A
Virus (FluAV, A/WSN/33 strain, delta NS1, i.e., infectious titer of
<106 plaque forming unit (PFU)/ml) were produced as previously
described [69] and kindly provided by Dr R. Le Goffic (Unite de
Virologie et Immunologie Moleculaires, Jouy-en-Josas, France).
Sixteen hours prior to co-culture with pDCs, Huh7.5 cells, which
are known to be deficient for the RIG-I signaling pathway [70],
were used to rule out the confounding contribution of IFNa
production by the infected cells themselves and infected at MOI of
0.1 and 0.5 for VSV-GFP and FluAV, respectively.
Introduction of mutations into the genomic length
DENV-2 strain NGC cDNA clone pDVWS601
Introduction of mutations into the genomic length DENV-2
strain NGC cDNA clone pDVWS601, encoding amino acid
substitutions into the E glycoprotein (i.e., H244A, D215A, P217A)
and NS5 (i.e., Rep2/2, containing the multiple amino acid
substitutions G81A, G83A and G85A) have been described
previously [31,32]. Mutations encoding amino acid substitutions
in prM (amino acids R88A/K90A/R91A) and an in frame four
amino acid deletion in the capsid (amino acids V51-to-L54) were
first introduced into DENV-2 subgenomic cDNA fragments by
overlap-PCR (OL-PCR) using mutagenic primers. The sequences
of the primers are described in the Table S1. The OL-PCR
fragments were purified and cleaved with BsrGI and SphI and
then transferred into the pDVWS601 plasmid that had been
cleaved with the corresponding restriction enzymes. The presence
of the mutations and sequence of the PCR derived regions were
confirmed by sequencing.
In vitro RNA transcripts were prepared from the parental and
mutated pDVWS601 plasmids as described above and transfected
into Huh7.5.1 cells using the Lipofectamine 2000 transfection
reagent (Life Technologies), according to the manufacturer’s
instruction. One mg of RNA was used to transfect a 60% confluent
cell monolayer contained in a single well of a 6-well plate following
the manufacturer’s protocol. Six hours post-transfection, the cells
were either harvested for the quantification of viral RNA (6 hour
time point) or washed 3 times with PBS and fresh culture medium
added to the cells for additional incubation times. At 24 and
48 hours post-transfection, the cells were harvested for the
determination of RNA and protein levels and their supernatants
collected for the quantification of viral RNA and infectious titer or
concentrated by ultracentrifugation for the determination of
protein levels by Western blot. At 24 hours post-transfection, the
cells were harvested and co-cultured with isolated pDCs for 18–
20 hours.
Co-culture experiments
Forty-eight hours prior to co-culture, cells were infected at a
MOI of 3 using a viral stock of WNV or DENV. Unless otherwise
indicated, 26104 pDCs were co-cultured with 105 infected cells,
transfected cells or uninfected parental cells, or treated with 100 ml
of supernatant from the latter cells in a 200 ml final volume in 96-
well round-bottom plates incubated at 37uC/5% CO2. Eighteen to
twenty hours later, cell-culture supernatants were collected and the
levels of IFNa, IFNb, TNFa and IL-6 were measured using a
commercially available ELISA kits specific for IFNa and IFNb
(PBL Interferon Source), TNFa and IL-6 (Affymetrix), following
the manufacturer’s instructions. When indicated, 105 infected cells
or uninfected cells were co-cultured with 36104 pDCs or with 105
naı¨ve recipient cells, as indicated, in 96-well format transwell
chambers separated by a 0.4 mm membrane (Corning).
Immunostaining and FACS analysis
At the indicated times, cells were harvested and resuspended
using 0.48 mM EDTA-PBS solution (Life Technologies). After
with extracellular prM:E ratios (J), intracellular DENV RNA (K), extracellular DENV RNA and infectious virus production (L), and quantification of IFNa
secretion by co-cultured pDCs (M). Results are expressed relative to 293T cells infected at a MOI of 1 in absence of Furin overexpression (indicated as
293T-1), set to 100 (error bars represent the means 6 SD, 3 independent experiments in triplicates). Arrows indicate results below the detection limit
of assay as described in the legend of Figure 6. NA; Not Applicable.
doi:10.1371/journal.ppat.1004434.g009
Immature Dengue Viral Particles Trigger IFN by pDC
PLOS Pathogens | www.plospathogens.org 17 October 2014 | Volume 10 | Issue 10 | e1004434
incubation with Fc receptor blocking reagent (MACS Miltenyi
Biotec) for 10 minutes at 4uC, surface staining of pDC markers,
CD123 and BDCA-2 and/or the cell differentiation markers
CD83 and CD86 were detected by a 40 minute incubation at 4uC
with 5 mg/mL of the indicated combinations of PE-conjugated
mouse anti-CD123, APC-conjugated anti-BDCA-2, PerCP-con-
jugated anti-CD83, and APC conjugated anti-CD86, respectively,
diluted in staining buffer (PBS without calcium and magnesium,
with 2% FBS), followed by PBS washes. Cells were then fixed
by incubation for 20 minutes at room temperature with 4%
paraformaldehyde, followed by 20 minutes incubation with 0.1 M
glycin-PBS at room temperature and two PBS washes. For
intracellular-immunostaining of IFNa, cocultivated cells were
treated with 1 ml/ml GolgiPlug solution (BD Bioscience) before
collection. After fixation and CD123-staining steps, IFNa was
detected by a 40 minute incubation with APC-conjugated mouse
anti- IFNa (MACS Miltenyi Biotec) diluted at 1:10 in permeabi-
lization buffer (BD Bioscience). Cells were then washed twice with
permeabilization buffer and resuspended in staining buffer. Flow
cytometric analysis was performed using a Digital LSR II, and the
data were analyzed with Flow Jo software (Tree Star). The
corresponding control isotypes served to define the specific signal.
Detection of DENV RNA in pDC-infected cell co-cultures
by Fluorescent In Situ Hybridization (FISH) analysis
After isolation, 56104 pDCs were stained by using 0.5 mM
Vibrant cell-labeling solution (CM-DiI, Life Technologies) by
successive incubations for 10 and 15 minutes at 37uC and 4uC
respectively. Labeled pDCs were washed twice with PBS and then
co-cultured with pre-plated DENV infected cells for 5 hours at
37uC in glass bottom 96 well-plate (Fisher Scientific), pretreated
with poly-L-lysine at 8 mg/mL. After 4% PFA fixation at room
temperature and PBS washing, DENV plus strand RNA was
detected using a probe set that targets a region between nucleotide
positions 8437-to-9685 in the DENV-2 NGC genome (Panomics/
Affymetrix) according to the manufacturer’s instructions. For
IFNa immunostaining, the cells were permeabilized by incubation
for 7 minutes in PBS containing 0.3% (v/v) Triton - and 3% (w/v)
BSA, then incubated with mouse anti-IFNa antibody (MACS
Miltenyi Biotec) at 2 mg/ml in PBS containing 3% BSA for
40 minutes at room temperature, followed by an incubation with
Alexa 647-conjugated anti-mouse antibody (Life Technologies)
and Hoechst dye for 40 minutes at room temperature. As controls,
FISH detection of DENV RNA were performed in co-cultures of
pDCs with non-infected cells and in co-cultures of pDCs with
DENV infected cells by omitting DENV-specific probe and by
following the same procedure of hybridization and immunostain-
ing. Images were acquired with a Zeiss LSM 710 laser scanning
confocal microscope and analyzed with Image J (http://rsb.info.
nih.gov/ij) and IMARIS (Bitplane Inc.) software packages.
Immuno-detection of DENV E and prM surface protein
and confocal analysis
After immune-isolation, pDCs were stained with 0.5 mM
Vibrant cell-labeling solution (CM-DiI) as above-described. 4-to-
56104 DiI-labeled pDCs (DiI-pDCs) were co-cultured with 4-to-
56104 DENV infected Huh7.5.1 cells for 8 hours at 37uC. For
analysis of DENV E and prM transfer into pDCs and cell contacts,
co-cultures were performed in LabTek II Chamber Slide System
(Nunc). After 4% PFA fixation and three PBS washes, cells were
permeabilized 7 min with 0.1% Triton in PBS prior immuno-
staining. For analysis of DENV surface protein clustering at the cell
contacts, co-cultures were incubated in a 96-Well Optical-Bottom
Plates. After 4% PFA fixation and three PBS washes, immuno-
stainings were performed without permeabilization step, as
previously described [71]. After blocking step (PBS 3% BSA)
actin filaments were stained with CF488A-conjugated phalloidin
(Biotium) at 1.25 U/mL, a-tubulin was stained with mouse anti-a
tubulin (DM1A clone, from Sigma) at 1:2000-dilution, DENV E
glycoproteins were detected using anti-E antibody (3H5 clone) at
1:500-dilution and anti-PrM antibody (DM-1 clone, Abcam) at
1:50-dilution and IFNa was detected by a mouse anti-IFNa
(Miltenyi) at 1:20-dilution. Antibodies were diluted in 3% BSA-
PBS and added to the cell for 1 hour incubation at room
temperature. After three PBS-washes with PBS, cells were
incubated with an Alexa 647-conjugated-anti-mouse antibody
(for detection of anti-a-tubulin and anti-E antibodies) or Alexa
488-conjugated-anti-mouse (for detection of anti-PrM antibody) at
1:1000-dilution in 3% BSA-PBS, added to the cells along with
Hoechst diluted at 1:500 (Molecular Probes) for 1 hour incubation
at room temperature. After three washes with PBS, cells in 96 wells
plate were directly observed and cells in Labtek were mounted
with mowiol prior observation. Images were acquired with a Zeiss
LSM 710 laser scanning confocal microscope and analyzed with
Image J (http://rsb.info.nih.gov/ij) and IMARIS (Bitplane Inc.)
software packages.
Analysis of intracellular and extracellular RNA levels
RNAs were isolated from cells or supernatants harvested in
guanidinium thiocyanate citrate buffer (GTC) by phenol/chloro-
form extraction procedure as previously [3]. The efficiency of
RNA extraction and reverse transcription-real-time quantitative
PCR (RT-qPCR) was controlled by the addition of carrier RNAs
encoding Xef1a (xenopus transcription factor 1a) in vitro
transcripts in supernatants diluted in GTC buffer. DENV RNA
and Xef1a and glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) mRNA levels were determined by RT-qPCR using
an iScript RT kit (Biorad) and a One-Step PCR Master Mix kit for
qPCR and analyzed using StepOnePlus Real-Time PCR system
(Life Technologies). The sequences of the primers used for the
RT-qPCR are described in Table S1. Extracellular and intracel-
lular DENV RNA levels were normalized for Xef1a and GAPDH
RNA levels, respectively.
Analysis of extracellular infectivity
Infectivity titers in supernatants were determined by end-point
dilution using Huh 7.5.1 cells. Foci forming unit (ffu) were detected
72 hours after infection by GFP expression for WNV and anti-E
glycoprotein specific immunofluorescence for DENV. Briefly, Huh
7.5.1 cells were fixed with 4% PFA and permeabilization by
incubation for 7 minutes in PBS containing 0.1% Triton. Cells
were then blocked in PBS containing 3% BSA for 15 minutes and
incubated for 1 hour with mouse anti-E glycoprotein (clone 3H5)
hybridoma supernatant diluted at 1:200 in PBS containing 1%
BSA. After 3 washes with PBS, cells were incubated 1 hour with
secondary Alexa 555-conjugated anti-mouse antibody (1:1’000-
dilution) and Hoechst dye (1:1’000-dilution) in PBS containing 1%
BSA. Percentage of E-positive cells and GFP expressing cells was
determined using a Zeiss Axiovert 135 microscope.
Analysis of concentrated viral supernatants and cell lysats
by western blot
Viral supernatant were filtrated through a 0.45 mm filter
(Corning) and concentrated prior to Western blot analysis by
ultracentrifugation at 110,0006 g for 2 hours at 4uC using a
SW41 rotor. The pellets were re-suspended in PBS. Viral pellets
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and cell lysates were extracted using lysis buffer (150 mM NaCl
50 mM Tris HCl pH 8, 1% NP40, 0.5% Deoxycholate, 0.1%
Sodium dodecyl sulfate) and analyzed by Western blotting using
hybridoma supernatant-containing anti-E (4G2) and anti-capsid
(6F3) at the dilution of 1:500 and actin at 1 mg/ml followed by
secondary horse radish peroxidase-coupled antibodies and chemi-
luminescence.
Imaging combined with flow cytometry analysis of pDC/
DENV cell conjugates
Huh 7.5.1 cells were transduced with retroviral based vector
pseudotyped with VSV glycoprotein to stably express GFP, as
previously described [72]. Forty-eight hours prior co-culture with
pDCs, GFP-expressing Huh 7.5.1 cells were infected at a MOI of
3 using a viral stock of DENV. 105 GFP-expressing DENV
infected cells were co-cultured with 36104 pDCs in low-adherence
micro-plate designed for cell harvesting by temperature reduction
(Nunc UpCell 96F Microwell Plate from Thermo Scientific) for
5 hours at 37uC in presence, or not, of Latrunculin B and
Nocodazole (1 mM), as indicated. After 4% PFA fixation, co-
cultured cells were harvested by equivalent multi-pipetting at room
temperature and washed three times with staining buffer (PBS
without calcium and magnesium with 2% FBS). After incubation
with Fc receptor blocking reagent (MACS Miltenyi Biotec) for
10 minutes at 4uC, surface staining of a pDC marker, CD123, was
detected by a 40 minute incubation at 4uC with 5 mg/mL of APC-
conjugated mouse anti-CD123, diluted in staining buffer, followed
by washes with staining buffer. Co-cultured cells were analyzed by
Image Stream X technology (Amnis) at magnification660 using
IDEAS software. The cell population defined as pDC/DENV cell
conjugates comprises conjugates of at least one CD123+ cell and
at least one cell solely GFP+ cell among the total of APC+ cells,
GFP+ cells and conjugates. The cell populations were sorted
by using masks (IDEAS software) to eliminate i/the non-specific
signals i.e., double positive single cells and ii/cells with
background levels for APC signal. Post-cell sorting, the accuracy
of the gated cell population in regards to the defined criteria was
controlled by a visual inspection of the individual pictures in the
gated cells population (i.e., assessment with 90 randomly picked
pictures of the population defined as conjugates). The percent-
ages of gated single cells or conjugates with an accurate
phenotype according to the defined criteria among the total of
examined pictures per category of cell population were: 97% for
GFP+ gated population, 99% for APC-CD123+ gated population
and 89% for conjugates.
Modulation of prM maturation and detection by ELISA
293T cells, which stably express furin, were generated by
transfection using Polyethylenimine and selected using hygro-
mycin (at 5 mg/ml). The decRRVKR-CMK inhibitor (Calbio-
chem) was used to inhibit the Furin activity in Huh7.5.1
co-cultured with the pDCs, as the indicated concentrations. The
levels of prM maturation were analyzed by detection of E and prM
by ELISA, as previously described [58]. Briefly serial dilutions of
viral supernatants were incubated on anti-E (4G2) antibody coated
96-well plate. Then, E and prM were detected by using a
humanized version of 3H5 mAb (hu3H5) and anti-prM, respec-
tively. The prM:E ratios were calculated using the viral
supernatant dilution with E detection in the linear range.
Expression of DENV glycoproteins
DENV-2 NGC prM and E genes were cloned under the control
of CMV promoter, by amplification from pSVprME [73] using
primers ADVprME_Fwd (GATCCCCGGGACCGCCACCAT-
GGTGAA) and ADVprME_REV (GATCCCCGGGAGCTT-
GATATCAGGCCTGC) and cloned into the Sma I site of the
adenovirus shuttle vector pDC104 under the control of the CMV
promoter to produce pAdvprME. AdvprME was transfected into
cells using the Xtreme-GENE HP DNA Transfection Reagent,
follow the manufacturer’s instructions. Six hours post-transfection,
the cells were washed with PBS and fresh culture medium added
to the cells for additional incubation times. At 48 hours post-
transfection, the cells were harvested and co-cultured with isolated
pDCs for 18–20 hours. Parallel determination of intracellular
protein levels by Western blot in harvested cells and their
supernatants concentrated by using vivaspin concentrator with
centrifugation at 3000 g for 30 min (cut-off 100 KDa, Sartorius).
Statistical analysis
Paired Student’s t-test was used to analyze data. Data
considered significant demonstrated p-values less than 0.05. Data
were also analyzed using a two ways non-parametrical analysis of
variance (ANOVA), followed by comparison with Levene Test,
analyzed with xlstat software. Triangles indicate the experimental
conditions that belong to a separated group statistically different
from the others.
Supporting Information
Figure S1 pDCs robustly produce IFNa in response to
DENV infected cells, related to Figure 1. pDC depletion or
enrichment was performed using an anti-BDCA-4 antibody. (A)
Representative FACS analysis of pDC depletion and isolation
from PBMCs using the pDC selective markers, CD123 and
BDCA-2. (B) Quantification of IFNa in the supernatants of 105
PBMCs, 105 pDC depleted-PBMCs and 103 isolated pDCs
(Responders) co-cultured with DENV infected BHK-21 cells
(DENV cells) or treated with 100 ml of supernatants from the latter
cells (DENV SN), in a 200 ml final volume. Viral titers in the
DENV SN were <0.756106 foci forming units (ffu)/ml.
Uninfected BHK-21 cells are referred to as control (cont) cells.
Arrows indicate results below the detection threshold of the IFNa
ELISA (i.e., 12.5 pg/ml). Results are representative of 3
independent experiments in triplicate. Error bars represent the
means 6 SD. (C) Parallel quantification of IL6 in the supernatants
of PBMCs or pDC-depleted PBMCs (Responders) triggered by
incubation with LPS (10 mg/mL for 20 hours). Results are
representative of 3 independent experiments in triplicates. Error
bars represent the means 6 SD.
(TIF)
Figure S2 Effect of infection time duration and of
varying the number of infected cells on pDC IFNa
secretion, related to Figure 1. (A) Quantification of IFNa
in the supernatants of pDCs co-cultured with DENV cells or
incubated with 100 ml of their supernatants (DENV SN) in a
200 ml final volume. Cells were infected at a MOI of 0.2 either 48
or 96 hours prior to co-culture, as indicated. Viral titers of the
DENV SN were <105 and 46105 ffu/ml at 48 and 96 hours,
respectively. Results of 2 independent experiments in duplicates.
Diamonds and histograms represent individual repeats and means,
respectively. (B–C) Quantification of IFNa in supernatants of
pDCs co-cultured with varying numbers of DENV infected cells
(DENV cells) (B) or WNV infected cells (WNV cells) (C), Results of
2 (B) and 3 (C) independent experiments in duplicates. Diamonds
and histograms represent individual repeats and means, respec-
tively. Uninfected cells are referred to as control (cont) cells.
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Arrows indicate results below the limit of detection of the IFNa
ELISA (i.e., 12.5 pg/ml). # cells; number of infected cells.
(TIF)
Figure S3 Cell-free virus containing supernatants fail to
trigger IFNa by pDCs. Quantification of IFNa in supernatants
of pDCs co-cultured with cells infected by DENV cells (A) or by
WNV (C) or inoculated with 100 ml of their supernatants (SN) that
were filtrated using 0.45 mm filters (filtration) or not (crude).
Arrows indicate results below the limit of detection of the IFNa
ELISA (i.e., 12.5 pg/ml). (B–D) Parallel determination of
infectious viral titers of DENV SN (B) and WNV SN (D). Results
are representative of 3 independent experiments in triplicates.
Error bars represent the means 6 SD.
(TIF)
Figure S4 pDCs are not permissive to DENV and WNV
infections. (A) Time course analysis of intracellular DENV RNA
levels by RT-qPCR. Results are expressed as fold increase relative
to the detection at 4 hours post-inoculation with a MOI of 1 for
Huh7.5.1 and MOI of 3 for pDCs. Results are expressed as the
fold increase of DENV genome equivalents (GE) relative to the
4 hour time point. Results of 2 independent experiments in
duplicates. Diamonds represent individual repeats. (B) Time
course analysis of the percentage of WNV-GFP positive cells after
inoculation with WNV-GFP at a MOI of 4 for 293T cells and
MOI of 12 for pDCs. Results are quantified by FACS. Results of 2
independent experiments in duplicates. Diamonds represent
individual repeats.
(TIF)
Figure S5 Specificity of the detection of DENV RNA
transferred from infected cells to pDCs by RNA FISH
assays, related to Figure 5. Confocal microscopy analysis of
DENV RNA detected by FISH in co-cultures of pDCs with
uninfected Huh-7.5.1 cells (Cont cells/pDCs) (A–B) and DENV
infected Huh-7.5.1 cells with omission of DENV-specific probe
(DENV cells/pDCs – no probe) (C–D). Cells were co-cultured for
5 hours, followed by the same procedure of hybridization and
immunostaining as described in Figure 5A. (A–C) Projections of
confocal microscopy analysis with DENV RNA (green), DiI-
stained pDC (red), IFNa protein (white) and nuclei (blue). Star
mark (*) indicates the pDC and hash mark (#) indicates the
Huh7.5.1 cell. (B–D) Consecutive Z-axis sections with magnifica-
tion of yellow-boxed pDC, shown in the corresponding panels (A)
and (C). Left panels, combined detections of DENV RNA (green),
DiI-stained pDC (red), IFNa protein (white). Their individual
detections are displayed on the right panels as indicated. Similar
results were obtained in 3 independent experiments.
(TIF)
Figure S6 Induction of ISG expressions by pDCs or
PBMCs co-cultured with DENV infected cells. Quantifica-
tion of intracellular MxA (A) and ISG56 (B) mRNA levels of pDCs
or PBMCs co-cultured or not with DENV infected Huh7.5.1 cells
(DENV cells). Results are expressed as fold increase relative to
corresponding co-culture with uninfected Huh7.5.1 (cont) cells. (C)
Parallel quantification of IFNa in supernatants of pDCs or
PBMCs co-cultured or not with DENV infected Huh7.5.1 cells
(DENV cells). Results of 2 independent experiments in duplicates.
Diamonds and histograms represent individual repeats and means,
respectively. Arrows indicate results below the limit of detection of
the IFNa ELISA (i.e., 12.5 pg/ml).
(TIF)
Figure S7 Impact of mutations in DENV NS5, capsid
and E and prM on intracellular and extracellular levels
of viral proteins, related to Figures 6 and 9. (A) The impact
of mutations on levels of intracellular DENV RNAs at the
indicated time post-transfection. Results are quantified by RT-
qPCR and expressed as DENV genome equivalent (GE)/mg total
RNA. (B–C) Representative Western blot analyses of intracellular
(B) and extracellular (C) DENV E and capsid protein levels.
Detection of the actin protein was used as a loading control. MW;
molecular weight markers in kDa. Results are representative of 3
independent experiments. (D) Effect of varying numbers of donor
cells on pDC IFNa secretion. Quantification of IFNa in
supernatants of pDCs co-cultured with varying numbers of cells
harboring the WT and mutant DENV genomes (means 6 SD,
n = 3). Cells harvested at 24 hours post-transfection were co-
cultured with pDCs for 20 hours. Uninfected cells are referred to
as control (-) cells. Arrows indicate results below the limit of
detection of the IFNa ELISA (i.e., 12.5 pg/ml).# cells; number of
infected cells.
(TIF)
Figure S8 Transfer of DENV E glycoproteins from cells
harboring the WT and mutant DENV genomes to co-
cultured pDCs, related to Figures 6 and 9. Left panels,
representative projections of confocal microscopy analysis of
DENV E glycoproteins (E GP, green) detected by immunostaining
in co-cultures of pDCs stained by DiI dye (red) and cells harboring
the WT genome (A), or genome with mutations in E, i.e.,
substitutions H244A (B) and P217A (C), with mutations in prM,
i.e., substitutions R88A, K90A and R91A (D) or cells devoid of
DENV genome, as control (E); nuclei (blue). Right panels,
consecutive Z-axis sections with magnification of yellow-boxed
pDC, shown in the corresponding left panels. Cell contours on E
GP panels are labeled with dotted lines surrounding DiI staining.
Yellow-arrows; E GP dots inside pDC. Star mark (*) and hash
mark (#) indicates the pDC and the Huh7.5.1 cell, respectively.
Similar results were obtained in 3 independent experiments and
summary table of the statistical analysis is displayed in Figure 6E.
(TIF)
Figure S9 Individual expression of DENV surface
proteins (i.e., E GP and prM) and their transmission
into the pDCs are not sufficient to trigger IFNa
production. Representative Western blot analyses of intracellu-
lar DENV E and capsid protein levels (A) and extracellular DENV
E protein levels (B) with cells expressing only DENV glycoproteins
(GP cells) as compared to DENV infected cells (DENV cells) and
uninfected parental cells (Cont cells). Detection of the actin protein
used as a loading control, MW; molecular weight markers in kDa.
Results are representative of 3 independent experiments. (C)
Quantification of IFNa in supernatants of pDCs co-cultured with
cells expressing only DENV glycoproteins (GP cells) as compared
to DENV infected cells (DENV cells) and uninfected parental cells
(Cont cells). Arrows indicate results below the limit of detection of
the IFNa ELISA (i.e. 12.5 pg/ml). Error bars represent the means
6 SD, results are representative of 3 independent experiments. (D)
Representative projections of confocal microscopy analysis of
DENV E glycoproteins (E GP, green) detected by immunostaining
in co-cultures of pDCs stained by DiI membrane dye (red) with
cells expressing DENV glycoproteins (GP cells) as compared to
DENV infected cells (DENV cells); nuclei (blue). Star mark (*):
pDCs and hash mark (#): Huh7.5.1 cells. (E) Consecutive Z-axis
sections with magnification of yellow-boxed pDC, shown in the
corresponding upper panels. Cell contours on the E GP panels are
labeled with dotted lines surrounding DiI staining. Yellow arrows;
E GP dots inside pDC. Similar results were obtained in 3
independent experiments. (F) Results expressed as the percentages
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of DiI stained pDCs containing E GP dot(s). Similar results were
obtained in 3 independent experiments and <20 pDCs,
surrounded by at least one E GP positive cell, were observed per
experimental condition.
(TIF)
Figure S10 Impact of internalization inhibitors on IFNa
production by pDCs co-cultured with DENV infected
cells. Impact of inhibitors of clathrin-mediated endocytosis
(chlorpromazine, CPZ, at 14 mM), of dynamin-dependent inter-
nalization (dynasore, at 100 mM) and macropinocytosis (Go¨6983-
PKC inhibitor, GO, at 5 mM) on pDC IFNa production triggered
by DENV infected cells. (A) Quantification of IFNa in the
supernatants of pDCs co-cultured with DENV infected Huh7.5.1
cells (DENV cells) or, as control, stimulated by TLR7 agonist the
R848 (50 ng/mL), an imidazoquinoline known as a cell-
permeable weak base that passively diffuses inside the pDCs.
Results are expressed relative to IFNa produced in absence of
inhibitor, set to 100 (means 6 SD, n = 4). Arrows indicate results
below the limit of detection of the IFNa ELISA (i.e., 12.5 pg/ml).
Quantification of the levels of infectious virus production (B) and
intracellular DENV genome equivalent (GE) (C) by Huh7.5.1 cells
infected by DENV at MOI 3 for 48 hours (as for the co-culture in
(A)) and then incubated, or not, with inhibitors, exactly as in (A)
(i.e. incubation time and concentration). Results are expressed as
percentages relative to untreated DENV cells (means 6 SD,
n = 4).
(TIF)
Figure S11 Impact of the cytoskeleton inhibitors on
microtubule network and FM4-64 internalization, relat-
ed to Figure 8. (A) Imaging of immunostained a-tubulin in co-
cultures of DiI-stained pDCs and DENV infected cells treated with
cytoskeleton inhibitors, exactly as in Figure 8A. Star mark (*):
pDCs and hash mark (#): Huh7.5.1 cells. Upper panels, confocal
microscopy analysis of a-tubulin (green); DiI-stained pDC (red);
nuclei (blue). Lower panels, magnification of yellow-boxed cell
contact shown in the corresponding upper pictures with tubulin-
DiI staining and phase contrast (left and right panels, respectively).
Similar results were obtained in 2 independent experiments. (B)
Imaging of the internalization of a lipophilic-dye, FM 4-64 (added
for 15 min incubation at 37uC) in co-cultures of pDCs and DENV
infected cells treated with cytoskeleton inhibitors, exactly as in
Figure 8A. Upper panels, confocal microscopy analysis of actin
(green); FM 4-64 (red); nuclei (blue). Lower panels, magnification
of yellow boxes shown in the corresponding upper pictures, with
actin-FM 4-64 and FM 4-64-phase contrast (left and right panels,
respectively).
(TIF)
Figure S12 Specificity of the immuno-detection of
DENV E and PrM clustering, related to Figure 7. Absence
of detection of E glycoprotein (E GP, purple) (A) and prM (green)
(B) in co-cultures of DiI-stained pDCs (red) with uninfected Huh
7.5.1 cells, analyzed exactly as in Figure 7F–K and 7L–Q,
respectively. Left panels, confocal analysis of DENV envelope
proteins, E GP (purple), prM (green), DiI-stained pDCs (Red),
actin detected by Alexa 488-conjugated phalloidin (green), when
indicated, and nuclei (blue). Middle panels, confocal microscopy
analysis of DENV envelope proteins and nuclei (blue) projected on
the phase contrast imaging. Right panels, confocal microscopy
analysis of DENV envelope proteins and nuclei (blue). Star mark
(*): pDCs and hash mark (#): Huh7.5.1 cells. Similar results were
obtained in 3 independent experiments.
(TIF)
Figure S13 Analysis of the conjugates between pDCs
and DENV infected cells by imaging flow cytometry
analysis, related to Figure 8B. Imaging flow cytometry
analysis (ImageStream) of DENV infected Huh7.5.1 cells, which
stably express GFP, and co-cultured with pDCs for 8 hours, as
described in the Figure 8B. pDCs are detected by the immuno-
staining of CD123, a pDC specific marker (APC-conjugated anti-
CD123 antibody). Representative pictures of the cell population
gated as conjugates between pDCs and GFP expressing DENV
infected cells (A), of the cell population gated as pDCs, single cells
(CD123 positive cells) (B), and of the cell population gated as
DENV infected cells,(GFP positive cells) (C). Panels, as displayed
from the left to the right, Bright field; GFP field; APC field; GFP/
APC field and Merge.
(TIF)
Figure S14 Transfer of DENV prM from DENV infected
cells into co-cultured pDCs. Left panels, representative
projections of confocal microscopy analysis of DENV prM (green)
detected by immunostaining in co-cultures of DiI-stained pDCs
(red) and DENV infected Huh7.5.1 cells (A), or uninfected (Cont)
cells (B); nuclei (blue). Right panels, consecutive Z-axis sections
with magnification of yellow-boxed pDC, shown in the corre-
sponding projection. Cell contours on the DENV prM panels are
labeled with dotted lines surrounding DiI staining. Yellow arrows;
DENV prM protein dot inside pDC. (C) Results expressed as the
percentages of DiI stained-pDCs containing prM protein dot(s).
Similar results were obtained in 3 independent experiments, with
<20 pDCs, surrounded by prM positive/DiI negative cell(s)
observed per experimental condition.
(TIF)
Table S1 Sequences of the primers for RT-qPCR and
cloning.
(DOCX)
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